18 May 2023
EuroPCR 2023 Industry Partner Interview: Edwards Lifesciences
Sponsored by Edwards Lifesciences
Summary
Listen to the interview with Bernard Zovighian, Chief Executive Officer, who explains Edwards Lifesciences' involvement in the 2023 edition of EuroPCR.
Involved in a number of studies on mitral, tricuspid and aortic valves, he insists on the BENCHMARK late-breaking trial, which shows that, with streamlined TAVR procedures, hospitals can reduce length of stay and intensive care unit time, while maintaining the high efficacy of TAVR.
Watch this video to find out more!
This interview was filmed at EuroPCR 2023: see more videos here!